Klijanienko J, Couturier J, Galut M, El-Naggar A K, Maciorowski Z, Padoy E, Mosseri V, Vielh P
Department of Pathology, Institut Curie, Paris, France.
Cancer. 1999 Oct 25;87(5):312-8. doi: 10.1002/(sici)1097-0142(19991025)87:5<312::aid-cncr12>3.0.co;2-5.
Fine-needle sampling, although a practical and noninvasive method of tissue acquisition, has rarely been used for HER-2/neu fluorescent in situ hybridization (FISH). To assess HER-2/neu gene amplification in mammary carcinoma, FISH signals on cytology and corresponding tissue biopsies were detected visually and measured by image analysis. The results were correlated with patient and tumor characteristics.
In situ HER-2/neu DNA probe hybridization was performed on 61 cytology specimens and on 47 corresponding frozen sections of breast carcinomas. Tumors were classified by visual evaluation as unamplified, moderately amplified, or highly amplified. Multiparametric image analysis was performed using the Discovery automated image analyzer (Becton Dickinson, Leiden, Netherlands). The integrated fluorescence ratio (IFR) was calculated for each sample as the integrated FISH fluorescence of the tumor cells divided by the integrated FISH fluorescence of internal control cells containing two spots. The percentage positive nuclear area (PPN), calculated as the area of FISH fluorescence divided by the area of nuclear DNA fluorescence, and the PPR, ratio of the PPN of the tumor cells divided by the control cells, were also calculated for each sample.
Visual analysis yielded 46 unamplified and 15 (24.6%) amplified (seven moderately amplified and eight highly-amplified) tumors. Strong (P < 0.001) correlation between results on cytological and histological materials was obtained. The FISH spots on the cytological preparations were more easily visualized and scored than those on the corresponding tissue sections. Visual HER-2/neu signal scoring was strongly correlated with IFR (P = 0.0001) and PPR (P = 0.0001). Within the tumors classified as highly amplified by visual examination, quantitation of the degree of amplification fluorescence signal was possible using image analysis.
Cytologic specimens were a suitable and representative source of materials for detection and quantitation of HER-2/neu gene amplification by FISH and image analysis. Cancer (Cancer Cytopathol)
细针采样虽是一种实用且无创的组织获取方法,但很少用于人表皮生长因子受体2(HER-2/neu)荧光原位杂交(FISH)。为评估乳腺癌中HER-2/neu基因扩增情况,通过视觉检测并借助图像分析测量了细胞学标本及相应组织活检标本上的FISH信号。结果与患者及肿瘤特征进行了关联分析。
对61例乳腺癌细胞学标本及47例相应的冰冻切片进行原位HER-2/neu DNA探针杂交。通过视觉评估将肿瘤分为未扩增、中度扩增或高度扩增。使用Discovery自动图像分析仪(荷兰莱顿贝克顿·迪金森公司)进行多参数图像分析。计算每个样本的积分荧光比率(IFR),即肿瘤细胞的FISH积分荧光除以含两个位点的内对照细胞的FISH积分荧光。还计算了每个样本的阳性核面积百分比(PPN),即FISH荧光面积除以核DNA荧光面积,以及肿瘤细胞与对照细胞PPN的比值(PPR)。
视觉分析显示46例肿瘤未扩增,15例(24.6%)扩增(7例中度扩增,8例高度扩增)。细胞学和组织学材料的结果之间存在强相关性(P<0.001)。细胞学标本上的FISH位点比相应组织切片上的更易于观察和评分。视觉HER-2/neu信号评分与IFR(P = 0.0001)和PPR(P = 0.0001)高度相关。在视觉检查分类为高度扩增的肿瘤中,使用图像分析可以对扩增荧光信号的程度进行定量。
细胞学标本是通过FISH和图像分析检测及定量HER-2/neu基因扩增的合适且具有代表性的材料来源。《癌症(癌症细胞病理学)》